Eviden revenue was €356 million in Q3 2025, up +77.1% organically compared to Q3 2024. This strong performance was mainly driven by the c.€200 million contribution from the Jupiter contract, partially ...
B&M shares plummeted by as much as 18 per cent to 178p during the opening moments of trading in London on Monday, reaching a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results